Jan 11, 2018 / Presentations The Medicare prescription drug program (Part D): Status report Research Areas: Beneficiaries and Coverage, Drugs, Devices, and Tests, Private Plans
Jan 03, 2018 / Comment Letters MedPAC comment on CMS’s proposed rule on the Medicare Advantage program (Part C) and Prescription Drug Benefit program (Part D) Research Areas: Beneficiaries and Coverage, Drugs, Devices, and Tests, Private Plans, Quality
Nov 03, 2017 / Presentations Biosimilars in Medicare Part D Research Areas: Beneficiaries and Coverage, Drugs, Devices, and Tests, Medicare Spending and Financing, Private Plans
Oct 02, 2017 / Reports October 2017 Report to the Congress: Regional Variation in Medicare Part A, Part B, and Part D Spending and Service Use Research Areas: Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Regional Issues
Sep 07, 2017 / Presentations Background on pharmacy benefit managers and specialty pharmacies Research Areas: Drugs, Devices, and Tests
Sep 07, 2017 / Presentations Primer on Medicare coverage policy Research Areas: Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests
Jun 15, 2017 / Reports June 2017 Report to the Congress: Medicare and the Health Care Delivery System Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality
Jun 15, 2017 / Press Releases MedPAC releases June 2017 Report to the Congress: Medicare and the Health Care Delivery System Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality
Jun 09, 2017 / Fact Sheets Fact sheet on MedPAC’s June 2017 Report to the Congress: Medicare and the Health Care Delivery System Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality